Promotional Campaigns in the Era of Social Platforms

The rise of social media has facilitated the diffusion of information to more easily reach millions of users. While some users connect with friends and organically share information and opinions on social media, others have exploited these platforms to gain influence and profit through promotional campaigns and advertising. The existence of promotional campaigns contributes to the spread of misleading information, spam, and fake news. Thus, these campaigns affect the trustworthiness and reliability of social media and render it as a crowd advertising platform. This dissertation studies the existence of promotional campaigns in social media and explores different ways users and bots (i.e. automated accounts) engage in such campaigns. In this dissertation, we design a suite of detection, ranking, and mining techniques. We study user-generated reviews in online e-commerce sites, such as Google Play, to extract campaigns. We identify cooperating sets of bots and classify their interactions in social networks such as Twitter, and rank the bots based on the degree of their malevolence. Our study shows that modern online social interactions are largely modulated by promotional campaigns such as political campaigns, advertisement campaigns, and incentive-driven campaigns. We measure how these campaigns can potentially impact information consumption of millions of social media users

Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin

BackgroundThere is mixed evidence about the relations of current versus past cancer with severe COVID-19 outcomes and how they vary by patient and cancer characteristics.MethodsElectronic health record data of 104,590 adult hospitalized patients with COVID-19 were obtained from 21 United States health systems from February 2020 through September 2021. In-hospital mortality and ICU admission were predicted from current and past cancer diagnoses. Moderation by patient characteristics, vaccination status, cancer type, and year of the pandemic was examined.Results6.8% of the patients had current (n = 7,141) and 6.5% had past (n = 6,749) cancer diagnoses. Current cancer predicted both severe outcomes but past cancer did not; adjusted odds ratios (aOR) for mortality were 1.58 [95% confidence interval (CI), 1.46-1.70] and 1.04 (95% CI, 0.96-1.13), respectively. Mortality rates decreased over the pandemic but the incremental risk of current cancer persisted, with the increment being larger among younger vs. older patients. Prior COVID-19 vaccination reduced mortality generally and among those with current cancer (aOR, 0.69; 95% CI, 0.53-0.90).ConclusionsCurrent cancer, especially among younger patients, posed a substantially increased risk for death and ICU admission among patients with COVID-19; prior COVID-19 vaccination mitigated the risk associated with current cancer. Past history of cancer was not associated with higher risks for severe COVID-19 outcomes for most cancer types.ImpactThis study clarifies the characteristics that modify the risk associated with cancer on severe COVID-19 outcomes across the first 20 months of the COVID-19 pandemic. See related commentary by Egan et al., p. 3